Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury

• Sponsor: Qin Zhang (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT06156098
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Anticipated Duration (Months): 13
• Patients Per Site Per Month: 7.7

Study Details

Study Description

Brief Summary

Exploring the predictive and evaluative value of various indicators of bedside critical renal ultrasound in critically ill patients with acute kidney injury (AKI)

Condition or Disease	Intervention/Treatment	Phase
Critical Illness	Other: No Intervention

Detailed Description

This study aims to perform bedside renal ultrasound examinations on critically ill patients admitted to the ICU (including sepsis, respiratory failure, shock, multiple trauma, etc.) and prospectively observe the relationship between ultrasound parameters and the occurrence and progression of AKI, in conjunction with traditional renal function indicators. This will provide clinicians with a rapid, non-invasive, and visual examination tool at the bedside for early diagnosis and treatment of AKI.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 100 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Bedside Renal Ultrasound Assessment in Critically Ill Patients With Acute Kidney Injury: an Observational Study
• Actual Study Start Date: Sep 1, 2023
• Anticipated Primary Completion Date: Nov 30, 2023
• Anticipated Study Completion Date: Sep 30, 2024

Outcome Measures

Primary Outcome Measures

1. Survival [28 days]

   28-day mortality rate

Secondary Outcome Measures

1. AKI [28 days]

   duration of continuous renal replacement therapy (CRRT)during hospitalization, length of hospital stay, duration of ICU stay, hospital mortality rate, 28-day mortality rate, and other relevant data.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 70 Years
• Sexes Eligible for Study: All

Inclusion Criteria:

• Age ≥ 18 years and ≤ 70 years

• Criteria for sepsis patients

Exclusion Criteria:

• Pregnant women.

• Patients with malignant tumors, severe heart failure, chronic renal insufficiency, end stage renal disease, kidney transplantation.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	Hubei	China	430030

Sponsors and Collaborators

• Qin Zhang

Investigators

• Principal Investigator: Qin Zhang, phd, Tongji Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Qin Zhang, Principal Investigator, Tongji Hospital
• ClinicalTrials.gov Identifier: NCT06156098
• Other Study ID Numbers: TJ-IRB202308105
• First Posted: Dec 5, 2023
• Last Update Posted: Dec 5, 2023
• Last Verified: Dec 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Qin Zhang, Principal Investigator, Tongji Hospital: Critical Illness; Ultrasound Therapy; Kidney injury
• Additional relevant MeSH terms: Acute Kidney Injury; Critical Illness

Study Results

No Results Posted as of Dec 5, 2023